Johnson & Johnson logo

Johnson & Johnson (JNJ)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
255. 56
+2.28
+0.9002%
After Hours
$
255. 65
+0.09 +0.0352%
618.09B Market Cap
29.06 P/E Ratio
0.69% Div Yield
6.37M Volume
9.91 Eps
$ 253.28
Previous Close
Add Transaction
Day Range
254 257.55
Year Range
184.66 281.07
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Seekingalpha | 4 months ago
What a $1 Million Dividend Portfolio Actually Pays After Federal AND State Taxes in California

What a $1 Million Dividend Portfolio Actually Pays After Federal AND State Taxes in California

A California retiree with a $1 million dividend portfolio earning a 5% blended yield grosses $50,000 in annual income.

247wallst | 4 months ago
Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

The six names below sit firmly in the conservative-to-moderate tier. Five are Dividend Kings or Aristocrats.

247wallst | 4 months ago
Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $231.73, marking a +1.05% move from the previous day.

Zacks | 4 months ago
3 Dividend Aristocrats to Own For a Lifetime Of Passive Income

3 Dividend Aristocrats to Own For a Lifetime Of Passive Income

Paychecks stop. Bonuses get cut.

247wallst | 4 months ago
Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

J&J's expanding pipeline, new drug approvals and rising sales from cancer medicines are expected to fuel growth.

Zacks | 5 months ago
This Will Be Johnson and Johnson's Stock Price in 2027

This Will Be Johnson and Johnson's Stock Price in 2027

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) closed the most recent session at $230.42, up 2.58% on the week as buyers rotated back into

247wallst | 5 months ago
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 5 months ago
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?

Zacks | 5 months ago
Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report?

Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock?

Zacks | 5 months ago
The 2 US Companies With a Better Credit Rating Than Uncle Sam Belong in Every Retirement Portfolio

The 2 US Companies With a Better Credit Rating Than Uncle Sam Belong in Every Retirement Portfolio

S&P Global rates only two U.S. public companies AAA, one notch above the federal government itself.

247wallst | 5 months ago
Loading...
Load More